GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Clinical Laboratory Tests Market is Segmented By Test Type (Complete Blood Count, Hgb/ Hct Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, Hba1c Testing, Comprehensive Metabolic Panel, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Others), By Application (Parasitology, Virology, Hematology, Toxicology, Immunology/serology, Histopathology And Urinalysis), By End User (Central Laboratories, Hospital Laboratories, Independent Laboratories, Research and Academia), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Clinical Laboratory Tests Market- Recent Developments

Product and Technology Launch

On August, 2023, Fapon, a China based biotechnology company that provides In vitro diagnostics (IVD) reagent raw material manufacturing company, launched chemiluminescence immunoassay system, Shine i8000/9000. The high-speed and fully automated analyzer has an ultra-high throughput of 900 tests per hour and features an integrated and compact design with stable performance.
On February 28, 2023, Cardio Diagnostics Holdings, U.S based biotechnology company specialized cardiovascular disease prevention and early detection launched artificial intelligence (AI)-based blood test PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
In December, 2021, Roche, a global pharmaceutical company, launchedthe first infectious disease tests and cobas oBni utility channel for use on the cobas 5800 system in countries accepting the Conformité Européenne (CE Mark)

Business Development Activities by the Market Players

On August, 2023, Labcorp, a global leader of innovative and comprehensive laboratory services, announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, U.S. This agreement will provide patients and providers of Tufts Medicine to have improved access to testing, reduced wait-times for patients, and standardized laboratory testing throughout the Tufts Medicine system by Labcorp.
In May 2022, OPKO Health, a multinational biopharmaceutical and diagnostics company announced acquisition of ModeX Therapeutics, a privately held biotechnology company. Through this acquisition OPKO Health broadens their technology foundation and expands the product pipeline to include multi-specific multi-functional antibodies focused on a range of cancers and infectious diseases.